FDA NDC Directory · JSON-LD · Markdown

ZYPREXA Zydis

NDC 0002-4453 · HUMAN PRESCRIPTION DRUG · TABLET, ORALLY DISINTEGRATING

Generic nameOlanzapine
Labeler / ManufacturerEli Lilly and Company
Marketing categoryNew Drug Application (innovator) · App NDA021086
Dosage form / routeTABLET, ORALLY DISINTEGRATING · ORAL
Active ingredientsOLANZAPINE (5 mg/1)
Marketing started20000601
Marketing ended20260630
Package count1

External sources

Source: openFDA. Public-domain (CC0).